{"entity":{"type":"insider","cik":"0001506218","url":"/insider/0001506218","json_url":"/insider/0001506218.json","name":"Hardiman Roy C.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":10,"n_filings":5,"first":"2019-12-13","last":"2026-08-05","span_basis":"filed_date"},"name_variants":[{"name":"Hardiman Roy C.","source":"filing","n_filings":5,"first_seen":"2019-12-13","last_seen":"2026-08-05"}],"transactions":[{"id":5994369,"accession":"0001506218-26-000005","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001506218-26-000005","line_url":"/filing/0001506218-26-000005#line-1","is_derivative":false,"issuer_cik":"0001506218","issuer_name":"ALUMIS INC.","issuer_ticker":"ALMS","issuer_name_source":null,"issuer_url":"/issuer/0001506218","owner_cik":"0001506218","owner_name":"Hardiman Roy C.","owner_display_name":"Hardiman Roy C.","owner_url":"/insider/0001506218","role":"Officer (Chief Business & Strategy Ofcr)","role_mark":"O","role_mark_label":"Officer (Chief Business & Strategy Ofcr)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business & Strategy Ofcr","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2692.0,"shares_display":"2,692","price_per_share":26.37,"price_display":"26.37","price_state":"stated","total_value":70988.04,"total_display":"70,988.04","total_whole":"70,988","shares_owned_after":207746.0,"shares_owned_after_display":"207,746","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-03","filed_date":"2026-08-05","scope":"insider"},{"id":3284404,"accession":"0001209191-20-051590","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-051590","line_url":"/filing/0001209191-20-051590#line-3","is_derivative":false,"issuer_cik":"0001506218","issuer_name":"Principia Biopharma Inc.","issuer_ticker":"PRNB","issuer_name_source":null,"issuer_url":"/issuer/0001506218","owner_cik":"0001506218","owner_name":"Hardiman Roy C.","owner_display_name":"Hardiman Roy C.","owner_url":"/insider/0001506218","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":99.9835,"price_display":"99.98","price_state":"stated","total_value":499917.5,"total_display":"499,917.50","total_whole":"499,918","shares_owned_after":117761.0,"shares_owned_after_display":"117,761","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-18","filed_date":"2020-09-22","scope":"insider"},{"id":2783138,"accession":"0001209191-20-036824","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-036824","line_url":"/filing/0001209191-20-036824","is_derivative":false,"issuer_cik":"0001506218","issuer_name":"Principia Biopharma Inc.","issuer_ticker":"PRNB","issuer_name_source":null,"issuer_url":"/issuer/0001506218","owner_cik":"0001506218","owner_name":"Hardiman Roy C.","owner_display_name":"Hardiman Roy C.","owner_url":"/insider/0001506218","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":61.1576758,"price_display":"61.16","price_state":"stated","total_value":305788.379,"total_display":"305,788.38","total_whole":"305,788","shares_owned_after":118624.0,"shares_owned_after_display":"118,624","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-12","filed_date":"2020-06-15","scope":"insider","n_lines":3},{"id":3112400,"accession":"0001209191-20-019667","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-019667","line_url":"/filing/0001209191-20-019667","is_derivative":false,"issuer_cik":"0001506218","issuer_name":"Principia Biopharma Inc.","issuer_ticker":"PRNB","issuer_name_source":null,"issuer_url":"/issuer/0001506218","owner_cik":"0001506218","owner_name":"Hardiman Roy C.","owner_display_name":"Hardiman Roy C.","owner_url":"/insider/0001506218","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":48.56316022,"price_display":"48.56","price_state":"stated","total_value":242815.8011,"total_display":"242,815.80","total_whole":"242,816","shares_owned_after":118184.0,"shares_owned_after_display":"118,184","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-13","filed_date":"2020-03-17","scope":"insider","n_lines":3},{"id":8352326,"accession":"0001209191-19-060531","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-19-060531","line_url":"/filing/0001209191-19-060531","is_derivative":false,"issuer_cik":"0001506218","issuer_name":"Principia Biopharma Inc.","issuer_ticker":"PRNB","issuer_name_source":null,"issuer_url":"/issuer/0001506218","owner_cik":"0001506218","owner_name":"Hardiman Roy C.","owner_display_name":"Hardiman Roy C.","owner_url":"/insider/0001506218","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":49.40677112,"price_display":"49.41","price_state":"stated","total_value":247033.8556,"total_display":"247,033.86","total_whole":"247,034","shares_owned_after":121762.0,"shares_owned_after_display":"121,762","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-13","filed_date":"2019-12-13","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":10,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":10,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":10},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001847367","name":"ALUMIS INC.","url":"/issuer/0001847367","role":"Officer (Chief Business & Strategy Ofcr)","n_filings":1,"first_seen":"2026-08-05","last_seen":"2026-08-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001510487","name":"Principia Biopharma Inc.","url":"/issuer/0001510487","role":"Officer (Chief Business Officer)","n_filings":4,"first_seen":"2019-12-13","last_seen":"2020-09-22"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001506218","retrieved_at":"2026-08-24T23:27:27+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}